Novel therapeutics in the treatment of drug-resistant tuberculosis: a review

Date
2023
DOI
Authors
Kearney, John Edward
Version
OA Version
Citation
Abstract
Mycobacterium tuberculosis is the causative agent of Tuberculosis infection (TB). TB is still endemic throughout the World and is a significant cause of morbidity and mortality, killing over 4,000 people every day. Although a number of antibiotics have been available for the treatment of TB since the late 1940s, treatment duration, drug-resistance, and barriers to effective health delivery have thwarted efforts for elimination (and eventually, eradication). Here is a compendium of several novel therapies that are being considered to address this global pandemic.
Description
License